BiomX Inc. Watch

from 10-K 31 pages Mtec Research Project Award Number: 001 Mtec Base Agreement Number: 1. Payment Method the Payment Method for This Research Project Award Is Cost Reimbursable With Cost Share Milestone With a Not to Exceed Ceiling. 2. Term of the Task Agreement the Period of Performance for This Research Project Award Is From the Date of Last Signature Through October 21, 2021. 3. Obligation the Mtec Cm’s Liability to Make Payments to the Research Project Awardee Is Limited to Only Those Funds Obligated Under This Research Project Award or by Modification to the Research Project Award. Mtec CM May Incrementally Fund This Research Project Award. 4. Estimated Cost and Cost Share the Total Estimated Cost and Cost Share for the Services to Be Provided by the Awardee Is as Follows: Estimated Cost Estimated Cost $ 9,637,711 Cost Share $ 990,559 Total Cost $ 10,628,270 5. Limitation of Costs

from 8-K 12 pages Placement Agency Agreement

from 8-K 13 pages Holder of Warrants Issued in March 2024 Re: Inducement Offer to Exercise Warrants Issued in March 2024 Dear Holder

from 8-K 27 pages Registration Rights Agreement

from 8-K 58 pages Securities Purchase Agreement

from 10-Q 14 pages BiomX Inc. 2019 Omnibus Long-Term Incentive Plan Restricted Stock Unit Agreement

from 8-K 19 pages Amended and Restated Chardan Healthcare Acquisition Corp. Long-Term Incentive Plan

from 10-Q 12 pages BiomX Inc. Indemnification Agreement

from 10-K 24 pages Sixth Amendment to Lease Agreement

from 10-K 3 pages Fifth Amendment to Lease Agreement

from 10-K 6 pages Fourth Amendment to Lease Agreement

from 10-K 6 pages Third Amendment to Lease Agreement

from 10-K 7 pages Second Amendment to Lease Agreement

from 10-K 6 pages First Amendment to Lease Agreement

from 10-K 29 pages Lease Agreement

from 10-K 2 pages Cui License Modification 1

from 10-K 11 pages Cui Biological Materials License Agreement

from 10-K 3 pages First Amendment to Exclusive Licence Between Adaptive Phage Therapeutics, Inc. and United States of America as Represented by the Secretary of the Navy

from 10-K 11 pages Exclusive License Between Adaptive Phage Therapeutics, Inc. and United States of America as Represented by the Secretary of the Navy

from 10-K 12 pages BiomX Inc. Indemnification Agreement